Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01787617 · ClinicalTrials.gov registry record · NA
Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men
A NA study of Type 2 Diabetes and Insulin Resistance, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
- 1
- Study location
NCT01787617: Completed NA study of Type 2 Diabetes and Insulin Resistance, sponsored by Pennington Biomedical Research Center.
NCT01787617 is a NA study of Type 2 Diabetes and Insulin Resistance that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 113 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01787617, a NA study of Type 2 Diabetes and Insulin Resistance, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the effect of an exercise training intervention on the ability of African American males to use insulin properly. Insulin is a hormone that helps the body use glucose.
Primary Outcome
An oral glucose tolerance test is a medical test in which glucose is given and blood samples are taken afterward to determine how quickly it is cleared from the blood. The test is usually used to test for diabetes or insulin resistance.
Conditions Studied
Interventions
- BEHAVIORAL Control Group
- BEHAVIORAL Aerobic Plus Resistance Training Group
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2012-12 |
| Est. Completion | 2018-03-31 |
| Phase | NA |
What the finished NCT01787617 record still lists
NCT01787617 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Control Group is the first listed.
NCT01787617 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT01787617 about?
NCT01787617 is a clinical study titled "Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men". The purpose of this study is to investigate the effect of an exercise training intervention on the ability of African American males to use insulin properly. Insulin is a hormone that helps the body use glucose.
What is the current status of trial NCT01787617?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2012-12. Estimated completion is 2018-03-31.
What conditions does trial NCT01787617 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Insulin Resistance.
What interventions are being tested in trial NCT01787617?
The interventions under investigation include: Control Group (BEHAVIORAL), Aerobic Plus Resistance Training Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01787617?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01787617 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01787617's enrollment target sits among peer trials
113 142nd of 327 higher than 185 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia